Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000

Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000–1

Published:2020-04-29 Issue:7 Volume:59 Page:825-832
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Poikonen-Saksela Paula¹^ORCID,Lindman Henrik²,Sverrisdottir Asgerdur³,Edlund Per⁴,Villman Kenneth⁵,Tennvall Nittby Lena⁶,Cold Søren⁷,Bechmann Troels⁸,Stenbygaard Lars⁹,Ejlertsen Bent¹⁰,Andersson Michael¹⁰,Blomqvist Carl¹⁵,Bergh Jonas¹¹,Ahlgren Johan⁴

Affiliation:

1. Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland;

2. Department of Immunology, Genetics and Pathology University Hospital, Uppsala, Sweden;

3. Department of Oncology, Södersjukhuset, Stocholm, Sweden;

4. Department of Oncology, Gävle Hospital, Sweden;

5. Department of Oncology, Örebro University Hospital, Örebro, Sweden;

6. Department of Oncology, Skåne University Hospital, Malmö, Sweden;

7. Department of Oncology, Odense University Hospital, Odense, Denmark;

8. Department of Oncology, Hospital of South West Jutland, Esbjerg, Denmark;

9. Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;

10. Department of Oncology, Rigshospitalet, Copenhagen, Denmark;

11. Department of Oncology-Pathology, Karolinska Institutet, Breast, Endocrine and Sarcoma Section, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2020.1757149

Reference56 articles.

1. How to calculate the dose of chemotherapy

2. Incidence and Predictors of Low Dose-Intensity in Adjuvant Breast Cancer Chemotherapy: A Nationwide Study of Community Practices

3. A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities

4. The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer

5. Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma;Cancer Medicine;2023-05-22

2. Anti-inflammatory effect of combining fish oil and evening primrose oil supplementation on breast cancer patients undergoing chemotherapy: a randomized placebo-controlled trial;Scientific Reports;2023-04-20

3. Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy;F1000Research;2022-07-01

4. Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy;F1000Research;2022-05-05

5. Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy;Cancer Medicine;2020-09-20